New Evidence on the Impact of Antithrombotics in Patients Submitted to Small Bowel Capsule Endoscopy for the Evaluation of Obscure Gastrointestinal Bleeding
Table 2
Baseline characteristics of patients under antiplatelet and anticoagulant drugs.
Characteristics
No antithrombotic
Antiplatelet user1
Anticoagulant user1
()
()
()
Age, y, mean (SD)
56.1 (18.7)
72.40 (12.7)2
71.8 (13.4)2
Female sex, (%)
109 (64.1)
44 (60.3)
22 (50.0)
Visible OGIB, (%)
30 (17.6)
13 (17.8)
10 (22.7)
Hemoglobin, g/dL (SD)
9.7 (2.1)
8.7 (1.9)2
8.7 (1.8)2
Comorbidity
Diabetes mellitus, (%)
34 (20.0)
36 (49.3)2
17 (38.6)
Arterial hypertension, (%)
69 (40.6)
53 (72.6)2
29 (65.9)2
Ischaemic heart disease, (%)
22 (12.9)
22 (30.1)2
17 (38.6)2
Chronic kidney disease, (%)
14 (8.2)
10 (13.7)
8 (18.2)
Thirteen patients were treated with both antiplatelet and anticoagulant drugs.
2.
